Inan industry built on volume and commission, Medicatessen's selective model isturning heads — and changing patient outcomes.
ISTANBUL — In thecompetitive world of health tourism, most agencies compete to grow theirprovider networks as fast as possible. Medicatessen competes by keeping itsnetwork small.
With a deliberatecap of two to three selected providers per city per medical specialty,Medicatessen rejects the wholesale model that has defined — and often damaged —the reputation of medical travel. Its founders argue that the sector'scredibility crisis is not a regulatory problem but a selection problem: toomany operators act as distributors rather than advisors, routing patients towhoever pays the highest commission.
"We turnaway the majority of doctors who approach us," said Medicatessen's ChiefMedical Advisor. "Not because they are bad doctors, but because we canonly recommend what we have verified. Verification takes time. Verificationrequires access. And verification means sometimes saying no to goodrevenue."
The agency'sevaluation framework assesses candidates across five dimensions: documentedclinical outcomes, peer-reviewed publications and citations, innovationcapacity and adoption of advanced techniques, institutional sustainability, andprofessional ethics. Social media presence is explicitly excluded as aselection criterion.
This approach hasattracted a patient demographic that traditional health tourism brokers rarelyreach: professionals, academics, and high-income individuals who havepreviously avoided medical travel due to trust concerns. For this segment,Medicatessen's combination of physical office presence, transparent pricing,and medically credentialed advisory services represents an entirely newcategory of offering.
Medicatessen nowoperates across four European cities with further expansion underway. ItsTurkish provider network spans Istanbul, Ankara, İzmir, Antalya, Muğla, andBursa, covering over fifty selected specialists in ten medical disciplines.
"Healthtourism grew for ten years on price," said Medicatessen's founder."The next ten years will be won on trust. We are building for that."

*JCI (Joint Commission International) is a global accreditation body setting international standards for healthcare quality and patient safety.
